Literature DB >> 11708431

Evaluation of the ILAR criteria for juvenile idiopathic arthritis.

M Krumrey-Langkammerer1, R Häfner.   

Abstract

OBJECTIVE: A pediatric rheumatology committee of ILAR has proposed new classification criteria for chronic childhood arthritis. The umbrella term "juvenile idiopathic arthritis (JIA)" was chosen and the disease was subdivided into 7 categories. Evaluation for these criteria is under way.
METHODS: We analyzed data of 200 consecutive children with rheumatic diseases.
RESULTS: In total 172 patients fulfilled criteria for JIA. Twenty-seven of these (15.7%) had to be grouped into the category "other arthritis": 16 met criteria for 2 categories; the other 11 did not fit into any category.
CONCLUSION: We suggest minor changes in the classification in order to classify 24 of these 27 patients into one of the specific categories without losing the claim for homogeneity in the different patient groups. Among the 44 patients with rheumatoid factor negative polyarthritis, 26 resembled oligoarthritis, with an extended oligoarticular joint pattern of 5 to 8 involved joints within the first 6 months. 18 had positive antinuclear antibodies, and 7 chronic uveitis. For these patients the introduction of a separate category "extended oligoarthritis at onset" should be considered to establish comparable patient groups.

Entities:  

Mesh:

Year:  2001        PMID: 11708431

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  22 in total

Review 1.  Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond.

Authors:  Robert A Colbert
Journal:  Nat Rev Rheumatol       Date:  2010-07-06       Impact factor: 20.543

2.  Atopy in children with the enthesitis-related arthritis (ERA) subtype of juvenile idiopathic arthritis is associated with a worse outcome.

Authors:  Ruru Guo; Lanfang Cao; Xianming Kong; Haiyan Xue; Xiaoli Li; Lijuan Shen
Journal:  Eur J Pediatr       Date:  2015-05-03       Impact factor: 3.183

3.  Juvenile idiopathic arthritis: management and therapeutic options.

Authors:  Natasha M Ruth; Murray H Passo
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

4.  [Therapeutic options in juvenile idiopathic arthritis : Surgical and conservative orthopedic rheumatological treatment].

Authors:  J-P Haas; M Arbogast
Journal:  Z Rheumatol       Date:  2021-04-21       Impact factor: 1.372

Review 5.  [Polyarticular juvenile idiopathic arthritis and rheumatoid arthritis : Common features and differences].

Authors:  Johannes-Peter Haas; Vincent Weimann; Eugen Feist
Journal:  Z Rheumatol       Date:  2021-10-28       Impact factor: 1.372

6.  Visual loss in uveitis of childhood.

Authors:  J de Boer; N Wulffraat; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

7.  Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis.

Authors:  Anna Corcione; Francesca Ferlito; Marco Gattorno; Andrea Gregorio; Angela Pistorio; Roberto Gastaldi; Claudio Gambini; Alberto Martini; Elisabetta Traggiai; Vito Pistoia
Journal:  Arthritis Res Ther       Date:  2009-10-05       Impact factor: 5.156

Review 8.  [Therapeutic options in juvenile idiopathic arthritis : Part 1: Nonsurgical treatment].

Authors:  J-P Haas; M Arbogast
Journal:  Orthopade       Date:  2018-11       Impact factor: 1.087

9.  Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.

Authors:  Matthew L Stoll; Alisa C Gotte
Journal:  Biologics       Date:  2008-06

10.  Development and validation of the RACER (Readiness for Adult Care in Rheumatology) transition instrument in youth with juvenile idiopathic arthritis.

Authors:  Lynn Spiegel; Lori Tucker; Karen Watanabe Duffy; Chitra Lalloo; Amos Hundert; Josiane Bourre-Tessier; Elizabeth Hazel; Nadia Luca; Dianne Mosher; Cynthia Nguyen; Elizabeth Stringer; Charles Victor; Jennifer Stinson
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.